Copyright Reports & Markets. All rights reserved.

Global Pneumonia Vaccine Market Research Report 2019

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Pneumonia Vaccine Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Pneumonia Vaccine Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Pneumonia Vaccine Market Size Growth Rate by Type
    • 1.4.2 Pneumococcal Conjugate Vaccine (PCV13)
    • 1.4.3 Pneumococcal Polysaccharide Vaccine (PPSV23)
  • 1.5 Market by Application
    • 1.5.1 Global Pneumonia Vaccine Market Size Growth Rate by Application
    • 1.5.2 Pneumonia
    • 1.5.3 Meningitis
    • 1.5.4 Sepsis
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Pneumonia Vaccine Market Size, Estimates and Forecasts
    • 2.1.1 Global Pneumonia Vaccine Revenue 2015-2026
    • 2.1.2 Global Pneumonia Vaccine Sales 2015-2026
  • 2.2 Global Pneumonia Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Pneumonia Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Pneumonia Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Pneumonia Vaccine Competitor Landscape by Players

  • 3.1 Pneumonia Vaccine Sales by Manufacturers
    • 3.1.1 Pneumonia Vaccine Sales by Manufacturers (2015-2020)
    • 3.1.2 Pneumonia Vaccine Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Pneumonia Vaccine Revenue by Manufacturers
    • 3.2.1 Pneumonia Vaccine Revenue by Manufacturers (2015-2020)
    • 3.2.2 Pneumonia Vaccine Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Pneumonia Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Pneumonia Vaccine Revenue in 2019
    • 3.2.5 Global Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Pneumonia Vaccine Price by Manufacturers
  • 3.4 Pneumonia Vaccine Manufacturing Base Distribution, Product Types
    • 3.4.1 Pneumonia Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Pneumonia Vaccine Product Type
    • 3.4.3 Date of International Manufacturers Enter into Pneumonia Vaccine Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Pneumonia Vaccine Market Size by Type (2015-2020)
    • 4.1.1 Global Pneumonia Vaccine Sales by Type (2015-2020)
    • 4.1.2 Global Pneumonia Vaccine Revenue by Type (2015-2020)
    • 4.1.3 Pneumonia Vaccine Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Pneumonia Vaccine Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Pneumonia Vaccine Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Pneumonia Vaccine Revenue Forecast by Type (2021-2026)
    • 4.2.3 Pneumonia Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Pneumonia Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Pneumonia Vaccine Market Size by Application (2015-2020)
    • 5.1.1 Global Pneumonia Vaccine Sales by Application (2015-2020)
    • 5.1.2 Global Pneumonia Vaccine Revenue by Application (2015-2020)
    • 5.1.3 Pneumonia Vaccine Price by Application (2015-2020)
  • 5.2 Pneumonia Vaccine Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Pneumonia Vaccine Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Pneumonia Vaccine Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Pneumonia Vaccine Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Pneumonia Vaccine by Country
    • 6.1.1 North America Pneumonia Vaccine Sales by Country
    • 6.1.2 North America Pneumonia Vaccine Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Pneumonia Vaccine Market Facts & Figures by Type
  • 6.3 North America Pneumonia Vaccine Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Pneumonia Vaccine by Country
    • 7.1.1 Europe Pneumonia Vaccine Sales by Country
    • 7.1.2 Europe Pneumonia Vaccine Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Pneumonia Vaccine Market Facts & Figures by Type
  • 7.3 Europe Pneumonia Vaccine Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Pneumonia Vaccine by Region
    • 8.1.1 Asia Pacific Pneumonia Vaccine Sales by Region
    • 8.1.2 Asia Pacific Pneumonia Vaccine Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Pneumonia Vaccine Market Facts & Figures by Type
  • 8.3 Asia Pacific Pneumonia Vaccine Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Pneumonia Vaccine by Country
    • 9.1.1 Latin America Pneumonia Vaccine Sales by Country
    • 9.1.2 Latin America Pneumonia Vaccine Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Pneumonia Vaccine Market Facts & Figures by Type
  • 9.3 Central & South America Pneumonia Vaccine Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Pneumonia Vaccine by Country
    • 10.1.1 Middle East and Africa Pneumonia Vaccine Sales by Country
    • 10.1.2 Middle East and Africa Pneumonia Vaccine Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Pneumonia Vaccine Market Facts & Figures by Type
  • 10.3 Middle East and Africa Pneumonia Vaccine Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Pfizer Inc.
    • 11.1.1 Pfizer Inc. Corporation Information
    • 11.1.2 Pfizer Inc. Description and Business Overview
    • 11.1.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Pfizer Inc. Pneumonia Vaccine Products Offered
    • 11.1.5 Pfizer Inc. Related Developments
  • 11.2 Glaxosmithkline Plc.
    • 11.2.1 Glaxosmithkline Plc. Corporation Information
    • 11.2.2 Glaxosmithkline Plc. Description and Business Overview
    • 11.2.3 Glaxosmithkline Plc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Glaxosmithkline Plc. Pneumonia Vaccine Products Offered
    • 11.2.5 Glaxosmithkline Plc. Related Developments
  • 11.3 Merck & Co., Inc.
    • 11.3.1 Merck & Co., Inc. Corporation Information
    • 11.3.2 Merck & Co., Inc. Description and Business Overview
    • 11.3.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Merck & Co., Inc. Pneumonia Vaccine Products Offered
    • 11.3.5 Merck & Co., Inc. Related Developments
  • 11.4 Sanofi Pasteur
    • 11.4.1 Sanofi Pasteur Corporation Information
    • 11.4.2 Sanofi Pasteur Description and Business Overview
    • 11.4.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Sanofi Pasteur Pneumonia Vaccine Products Offered
    • 11.4.5 Sanofi Pasteur Related Developments
  • 11.5 Serum Institute of India Pvt. Ltd.
    • 11.5.1 Serum Institute of India Pvt. Ltd. Corporation Information
    • 11.5.2 Serum Institute of India Pvt. Ltd. Description and Business Overview
    • 11.5.3 Serum Institute of India Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Products Offered
    • 11.5.5 Serum Institute of India Pvt. Ltd. Related Developments
  • 11.6 Johnson & Johnson
    • 11.6.1 Johnson & Johnson Corporation Information
    • 11.6.2 Johnson & Johnson Description and Business Overview
    • 11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Johnson & Johnson Pneumonia Vaccine Products Offered
    • 11.6.5 Johnson & Johnson Related Developments
  • 11.7 Astellas Pharma Inc.
    • 11.7.1 Astellas Pharma Inc. Corporation Information
    • 11.7.2 Astellas Pharma Inc. Description and Business Overview
    • 11.7.3 Astellas Pharma Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Astellas Pharma Inc. Pneumonia Vaccine Products Offered
    • 11.7.5 Astellas Pharma Inc. Related Developments
  • 11.8 Astrazeneca Plc.
    • 11.8.1 Astrazeneca Plc. Corporation Information
    • 11.8.2 Astrazeneca Plc. Description and Business Overview
    • 11.8.3 Astrazeneca Plc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Astrazeneca Plc. Pneumonia Vaccine Products Offered
    • 11.8.5 Astrazeneca Plc. Related Developments
  • 11.9 CSL Limited
    • 11.9.1 CSL Limited Corporation Information
    • 11.9.2 CSL Limited Description and Business Overview
    • 11.9.3 CSL Limited Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 CSL Limited Pneumonia Vaccine Products Offered
    • 11.9.5 CSL Limited Related Developments
  • 11.10 Emergent Biosolutions
    • 11.10.1 Emergent Biosolutions Corporation Information
    • 11.10.2 Emergent Biosolutions Description and Business Overview
    • 11.10.3 Emergent Biosolutions Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Emergent Biosolutions Pneumonia Vaccine Products Offered
    • 11.10.5 Emergent Biosolutions Related Developments
  • 11.1 Pfizer Inc.
    • 11.1.1 Pfizer Inc. Corporation Information
    • 11.1.2 Pfizer Inc. Description and Business Overview
    • 11.1.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Pfizer Inc. Pneumonia Vaccine Products Offered
    • 11.1.5 Pfizer Inc. Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Pneumonia Vaccine Market Estimates and Projections by Region
    • 12.1.1 Global Pneumonia Vaccine Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Pneumonia Vaccine Revenue Forecast by Regions 2021-2026
  • 12.2 North America Pneumonia Vaccine Market Size Forecast (2021-2026)
    • 12.2.1 North America: Pneumonia Vaccine Sales Forecast (2021-2026)
    • 12.2.2 North America: Pneumonia Vaccine Revenue Forecast (2021-2026)
    • 12.2.3 North America: Pneumonia Vaccine Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Pneumonia Vaccine Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Pneumonia Vaccine Sales Forecast (2021-2026)
    • 12.3.2 Europe: Pneumonia Vaccine Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Pneumonia Vaccine Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Pneumonia Vaccine Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Pneumonia Vaccine Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Pneumonia Vaccine Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Pneumonia Vaccine Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Pneumonia Vaccine Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Pneumonia Vaccine Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Pneumonia Vaccine Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Pneumonia Vaccine Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Pneumonia Vaccine Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Pneumonia Vaccine Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Pneumonia Vaccine Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Pneumonia Vaccine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Pneumonia Vaccine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Pneumonia Vaccine Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Pneumonia Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pneumonia Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Pneumonia Vaccine market is segmented into
    Pneumococcal Conjugate Vaccine (PCV13)
    Pneumococcal Polysaccharide Vaccine (PPSV23)

    Segment by Application, the Pneumonia Vaccine market is segmented into
    Pneumonia
    Meningitis
    Sepsis

    Regional and Country-level Analysis
    The Pneumonia Vaccine market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Pneumonia Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Pneumonia Vaccine Market Share Analysis
    Pneumonia Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pneumonia Vaccine business, the date to enter into the Pneumonia Vaccine market, Pneumonia Vaccine product introduction, recent developments, etc.

    The major vendors covered:
    Pfizer Inc.
    Glaxosmithkline Plc.
    Merck & Co., Inc.
    Sanofi Pasteur
    Serum Institute of India Pvt. Ltd.
    Johnson & Johnson
    Astellas Pharma Inc.
    Astrazeneca Plc.
    CSL Limited
    Emergent Biosolutions

    Buy now